[
    {
        "question_id": "999_B_2160",
        "new_question_id": "61241",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "1488",
        "notes_id_link": "1_1169",
        "theme": "Investigation for suspected spontaneous bacterial peritonitis",
        "instruction": "",
        "options": [
            "",
            "Ascitic fluid neutrophil count",
            "Blood cultures",
            "Serum C-reactive protein",
            "Abdominal ultrasound scan",
            "Serum lactate",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 62-year-old man with known alcohol-related liver disease and ascites is admitted with a 2-day history of fever, confusion, and generalised abdominal tenderness. His observations are stable.<br /><br />Select the single most appropriate investigation to confirm the diagnosis from the options below.",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>Ascitic fluid neutrophil count</b> is the correct answer. This patient presents with features highly suggestive of Spontaneous Bacterial Peritonitis (SBP), a common and life-threatening complication in patients with cirrhosis and ascites. The clinical features can be subtle and include fever, abdominal pain, or worsening encephalopathy, as seen in this case. The gold standard for diagnosis is an urgent diagnostic paracentesis (ascitic tap). An ascitic fluid absolute neutrophil count of \u2265250 cells/mm\u00b3 (or 0.25 x 10\u2079/L) is diagnostic of SBP. This investigation is crucial as it allows for the prompt initiation of empirical intravenous antibiotics (e.g., a third-generation cephalosporin like cefotaxime), which significantly improves outcomes. Treatment should not be delayed while awaiting culture results, which are often negative (culture-negative neutrocytic ascites).<br /><br /><b>Blood cultures</b> are an important investigation in any patient with suspected sepsis and should be performed in this patient as part of a full septic screen. Bacteraemia can occur concurrently with SBP. However, blood cultures are not the primary diagnostic tool for SBP itself. They are only positive in approximately 40% of SBP cases, meaning a negative result does not exclude the diagnosis. Therefore, while a necessary investigation, they do not have the same diagnostic primacy as ascitic fluid analysis for confirming SBP.<br /><br /><b>Serum C-reactive protein</b> (CRP) is a non-specific marker of inflammation. While it is likely to be elevated in a patient with SBP, it lacks diagnostic specificity. Many other conditions, both infectious and non-infectious, can cause a raised CRP. Furthermore, patients with advanced liver disease have impaired hepatic synthesis of acute-phase proteins, which can lead to a blunted or unreliable CRP response. Therefore, it cannot be used to confirm or exclude SBP and is only a supportive finding.<br /><br />An <b>Abdominal ultrasound scan</b> is a useful adjunct in this scenario. It can confirm the presence of ascites, identify a safe pocket of fluid for paracentesis (especially if ascites is minimal or loculated), and help to exclude other intra-abdominal pathologies such as a visceral perforation or abscess (secondary bacterial peritonitis). However, the ultrasound scan itself cannot diagnose SBP, as the sonographic appearance of infected and sterile ascitic fluid is indistinguishable. Its role is supportive and procedural, not diagnostic.<br /><br /><b>Serum lactate</b> is a key investigation in the assessment and management of sepsis. An elevated lactate level indicates tissue hypoperfusion and is associated with a worse prognosis. It is part of the 'Sepsis Six' care bundle and helps guide fluid resuscitation and overall management of the septic patient. However, like CRP, it is a non-specific marker of systemic illness and does not provide any information about the source of infection. It is vital for prognostication and management but not for diagnosing SBP.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 62-year-old man with known alcohol-related liver disease and ascites is admitted with a 2-day history of fever, confusion, and generalised abdominal tenderness. His observations are stable.<br /><br />Select the single most appropriate investigation to confirm the diagnosis from the options below.",
        "correct_answer": "1",
        "question_notes": "<b>Ascitic fluid neutrophil count</b> is the correct answer. This patient presents with features highly suggestive of Spontaneous Bacterial Peritonitis (SBP), a common and life-threatening complication in patients with cirrhosis and ascites. The clinical features can be subtle and include fever, abdominal pain, or worsening encephalopathy, as seen in this case. The gold standard for diagnosis is an urgent diagnostic paracentesis (ascitic tap). An ascitic fluid absolute neutrophil count of \u2265250 cells/mm\u00b3 (or 0.25 x 10\u2079/L) is diagnostic of SBP. This investigation is crucial as it allows for the prompt initiation of empirical intravenous antibiotics (e.g., a third-generation cephalosporin like cefotaxime), which significantly improves outcomes. Treatment should not be delayed while awaiting culture results, which are often negative (culture-negative neutrocytic ascites).<br /><br /><b>Blood cultures</b> are an important investigation in any patient with suspected sepsis and should be performed in this patient as part of a full septic screen. Bacteraemia can occur concurrently with SBP. However, blood cultures are not the primary diagnostic tool for SBP itself. They are only positive in approximately 40% of SBP cases, meaning a negative result does not exclude the diagnosis. Therefore, while a necessary investigation, they do not have the same diagnostic primacy as ascitic fluid analysis for confirming SBP.<br /><br /><b>Serum C-reactive protein</b> (CRP) is a non-specific marker of inflammation. While it is likely to be elevated in a patient with SBP, it lacks diagnostic specificity. Many other conditions, both infectious and non-infectious, can cause a raised CRP. Furthermore, patients with advanced liver disease have impaired hepatic synthesis of acute-phase proteins, which can lead to a blunted or unreliable CRP response. Therefore, it cannot be used to confirm or exclude SBP and is only a supportive finding.<br /><br />An <b>Abdominal ultrasound scan</b> is a useful adjunct in this scenario. It can confirm the presence of ascites, identify a safe pocket of fluid for paracentesis (especially if ascites is minimal or loculated), and help to exclude other intra-abdominal pathologies such as a visceral perforation or abscess (secondary bacterial peritonitis). However, the ultrasound scan itself cannot diagnose SBP, as the sonographic appearance of infected and sterile ascitic fluid is indistinguishable. Its role is supportive and procedural, not diagnostic.<br /><br /><b>Serum lactate</b> is a key investigation in the assessment and management of sepsis. An elevated lactate level indicates tissue hypoperfusion and is associated with a worse prognosis. It is part of the 'Sepsis Six' care bundle and helps guide fluid resuscitation and overall management of the septic patient. However, like CRP, it is a non-specific marker of systemic illness and does not provide any information about the source of infection. It is vital for prognostication and management but not for diagnosing SBP.",
        "answer_order": "1",
        "answer": "1",
        "title": "Spontaneous bacterial peritonitis",
        "body": "Spontaneous bacterial peritonitis (SBP) is a form of peritonitis usually seen in patients with ascites secondary to liver cirrhosis.<br /><br /><span class=\"concept\" data-cid=\"10051\">Features</span><br /><ul><li>ascites</li><li>abdominal pain</li><li>fever</li></ul><br />Diagnosis<br /><ul><li>paracentesis: <span class=\"concept\" data-cid=\"1488\">neutrophil count > 250 cells/ul</span></li><li>the most common organism found on ascitic fluid culture is <span class=\"concept\" data-cid=\"5499\"><i>E. coli</i></span></li></ul><br />Management<br /><ul><li><span class=\"concept\" data-cid=\"192\">intravenous cefotaxime</span> is usually given</li></ul><br />Antibiotic prophylaxis should be given to patients with ascites if:<br /><ul><li>patients who have <span class=\"concept\" data-cid=\"4464\">had an episode of SBP</span></li><li>patients with fluid protein <15 g/l and either Child-Pugh score of at least 9 or hepatorenal syndrome</li><li>NICE recommend: '<i>Offer prophylactic <span class=\"concept\" data-cid=\"1004\">oral ciprofloxacin or norfloxacin</span> for people with cirrhosis and ascites with an ascitic protein of 15 g/litre or less until the ascites has resolved</i>'</li></ul><br />Alcoholic liver disease is a marker of poor prognosis in SBP.",
        "notes_hash": "bb71667950305cbbb90a1f3df17c1e82",
        "knowledge_graph_node_id_link": 0,
        "concept": "In suspected SBP- diagnosis is by paracentesis. Confirmed by neutrophil count >250 cells/ul",
        "concept_percentile": "88",
        "concept_colour": "rgb(61,255,0)",
        "number_attempts": "210",
        "up_votes": "0",
        "down_votes": "1",
        "column_array": [
            0,
            "183",
            "0",
            "3",
            "16",
            "8",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>European Association for the Study of the Liver</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1605\" data-linkid=\"1605\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1605\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">13</span><button type=\"button\" style=\"\" id=\"link_dislike_1605\" data-linkid=\"1605\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1605\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://easl.eu/wp-content/uploads/2018/10/Hepatorenal-Cirrhosis-English-report.pdf\">2010 EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis</a></td></tr></table><br><br><table style='width:100%'><tr><td>British Society of Gastroenterology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_744\" data-linkid=\"744\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_744\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">10</span><button type=\"button\" style=\"\" id=\"link_dislike_744\" data-linkid=\"744\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_744\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.bsg.org.uk/wp-content/uploads/2020/10/gutjnl-2020-321790.full_.pdf\">Guidelines on the management of ascites in cirrhosis</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Igb1rta3-c4\" data-description=\"Spontaneous bacterial peritonitis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"1406\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Igb1rta3-c4/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Igb1rta3-c4\" data-description=\"Spontaneous bacterial peritonitis\" data-upvotes=\"6\" data-downvotes=\"0\" data-media=\"1406\">Spontaneous bacterial peritonitis</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2473\" data-mediaid=\"2473\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2473\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_2473\" data-mediaid=\"2473\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2473\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "1004": {
                "concept_text": "Patients with ascites (and protein concentration <= 15 g/L) should be given oral ciprofloxacin or norfloxacin as prophylaxis against spontaneous bacterial peritonitis",
                "concept_percentile": "93"
            },
            "1488": {
                "concept_text": "In suspected SBP- diagnosis is by paracentesis. Confirmed by neutrophil count >250 cells/ul",
                "concept_percentile": "88"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1834",
        "new_question_id": "7624",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "0",
        "notes_id_link": "1_274",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Pulmonary embolism",
            "Anterior myocardial infarction",
            "Acute pericarditis",
            "Hypertrophic obstructive cardiomyopathy",
            "Brugada syndrome",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 36-year-old man presents to the Emergency Department with chest pain. This started around 2 hours ago and is described as severe. The pain is central, with no radiation. It is not worse on deep inspiration.<br /><br />He smokes 10 cigarettes/day but is otherwise fit and well. His father had a myocardial infarction at the age of 61 years. Examination of the cardiovascular system is unremarkable with a blood pressure of 136/84 mmHg, pulse 96/min, respiratory rate 14/min and saturations 98% on room air.<br /><br />An ECG is taken:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://hqmeded-ecg.blogspot.com/'  target='_blank' style = 'font-size:11px; color:LightGray;' >Dr Smith, University of Minnesota</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a><a  border='0' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062c.jpg'  \n\t\ttarget='_blank' ><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass2.png'/></a></td></tr></table></CENTER><br />What is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "The ECG shows widespread ST elevation but the most diagnostic feature of the ECG is the PR depression - this is very specific for pericarditis and makes the diagnosis clear.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 36-year-old man presents to the Emergency Department with chest pain. This started around 2 hours ago and is described as severe. The pain is central, with no radiation. It is not worse on deep inspiration.<br /><br />He smokes 10 cigarettes/day but is otherwise fit and well. His father had a myocardial infarction at the age of 61 years. Examination of the cardiovascular system is unremarkable with a blood pressure of 136/84 mmHg, pulse 96/min, respiratory rate 14/min and saturations 98% on room air.<br /><br />An ECG is taken:<br /><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>&copy; Image used on license from </span><a href='http://hqmeded-ecg.blogspot.com/'  target='_blank' style = 'font-size:11px; color:LightGray;' >Dr Smith, University of Minnesota</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a><a  border='0' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062c.jpg'  \n\t\ttarget='_blank' ><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass2.png'/></a></td></tr></table></CENTER><br />What is the most likely diagnosis?",
        "correct_answer": "3",
        "question_notes": "The ECG shows widespread ST elevation but the most diagnostic feature of the ECG is the PR depression - this is very specific for pericarditis and makes the diagnosis clear.",
        "answer_order": "3",
        "answer": "3",
        "title": "Acute pericarditis",
        "body": "Acute pericarditis is a condition referring to inflammation of the pericardial sac, lasting for less than 4-6 weeks.<br /><br />Aetiology<br /><ul><li>viral infections (Coxsackie)</li><li>tuberculosis</li><li><span class=\"concept\" data-cid=\"3898\">uraemia</span></li><li>post-myocardial infarction<ul><li>early (1-3 days): fibrinous pericarditis</li><li>late (weeks to months): autoimmune pericarditis (Dressler's syndrome)</li></ul></li><li>radiotherapy</li><li>connective tissue disease<ul><li>systemic lupus erythematosus</li><li>rheumatoid arthritis</li></ul></li><li>hypothyroidism</li><li><span class=\"concept\" data-cid=\"2989\">malignancy</span><ul><li>lung cancer</li><li>breast cancer</li></ul></li><li>trauma</li></ul><br />Features<br /><ul><li>chest pain: may be pleuritic. <span class=\"concept\" data-cid=\"5267\">Is often relieved by sitting forwards</span></li><li>other symptoms include a non-productive cough, dyspnoea and flu-like symptoms</li><li><span class=\"concept\" data-cid=\"4696\">pericardial rub</span></li></ul><br />Investigations<br /><ul><li>ECG changes<ul><li>the changes in pericarditis are often <span class=\"concept\" data-cid=\"9669\">global/widespread</span>, as opposed to the 'territories' seen in ischaemic events</li><li><span class=\"concept\" data-cid=\"1281\">'saddle-shaped' ST elevation</span> </li><li><span class=\"concept\" data-cid=\"2988\">PR depression: most specific ECG marker for pericarditis</span></li></ul></li><li><span class=\"concept\" data-cid=\"9750\">all patients with suspected acute pericarditis should have transthoracic echocardiography</span></li><li>bloods<ul><li>inflammatory markers</li><li>troponin: around 30% of patients may have an elevated troponin - this indicates possible myopericarditis</li></ul></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062b.jpg\" data-fancybox=\"gallery\" data-caption=\"ECG showing pericarditis. Note the widespread nature of the ST elevation and the PR depression- e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg062.jpg\" alt=\"\" /></a></div><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg083b.png\" data-fancybox=\"gallery\" data-caption=\"ECG showing changes consistent with acute pericarditis in a young woman. Widespread ST elevation without reciprocal changes. Marked PR depression - e Image used on license from Dr Smith, University of Minnesota\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/ecg083.png\" alt=\"\" /></a></div></div></div><br />Management<br /><ul><li>the majority of patients can be managed as outpatients<ul><li>patients who have high-risk features such as fever > 38\u00b0C or elevated troponin should be managed as an inpatient</li></ul></li><li>treat any underlying cause<ul><li>most patients however will have pericarditis secondary to viral infection, meaning no specific treatment is indicated</li></ul></li><li>strenuous physical activity should be avoided until symptom resolution and normalisation of inflammatory markers<ul><li> athletes should avoid strenuous exercise for at least 3 months until symptoms have resolved and investigations (CRP, ECG, and echocardiography) have normalised</li></ul></li><li><span class=\"concept\" data-cid=\"9697\">a combination of NSAIDs and colchicine is now generally used for first-line for patients with acute idiopathic or viral pericarditis</span><ul><li>therapy is continued until symptom resolution and normalisation of inflammatory markers (usually 1\u20132 weeks), followed by a taper of the dose over a further 2\u20134 weeks</li></ul></li></ul>",
        "notes_hash": "e2185768fed4f20c69845aa9f0681d4b",
        "knowledge_graph_node_id_link": 1001,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6828",
        "up_votes": "99",
        "down_votes": "147",
        "column_array": [
            0,
            "168",
            "2581",
            "3188",
            "391",
            "500",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Life in the fast lane</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_533\" data-linkid=\"533\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_533\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">40</span><button type=\"button\" style=\"\" id=\"link_dislike_533\" data-linkid=\"533\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_533\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">16</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://litfl.com/pericarditis-ecg-library/\">Pericarditis review</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/O4sHhmfRaFg\" data-description=\"Myopericarditis Explained - Myocarditis & Pericarditis\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1382\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/O4sHhmfRaFg/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/O4sHhmfRaFg\" data-description=\"Myopericarditis Explained - Myocarditis & Pericarditis\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1382\">Myopericarditis Explained - Myocarditis & Pericarditis</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2433\" data-mediaid=\"2433\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2433\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2433\" data-mediaid=\"2433\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2433\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/BXfnlCebHHE\" data-description=\"Pericarditis\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1506\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/BXfnlCebHHE/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/BXfnlCebHHE\" data-description=\"Pericarditis\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1506\">Pericarditis</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2651\" data-mediaid=\"2651\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2651\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2651\" data-mediaid=\"2651\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2651\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lxE4xgjE31E\" data-description=\"Pericarditis and pericardial effusions\" data-upvotes=\"18\" data-downvotes=\"2\" data-media=\"363\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/lxE4xgjE31E/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lxE4xgjE31E\" data-description=\"Pericarditis and pericardial effusions\" data-upvotes=\"18\" data-downvotes=\"2\" data-media=\"363\">Pericarditis and pericardial effusions</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_613\" data-mediaid=\"613\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_613\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">18</span><button type=\"button\" style=\"\" id=\"media_dislike_613\" data-mediaid=\"613\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_613\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/IhVEiTO3npA\" data-description=\"Pericardial rub - REQUIRES HEADPHONES\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"186\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/IhVEiTO3npA/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/IhVEiTO3npA\" data-description=\"Pericardial rub - REQUIRES HEADPHONES\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"186\">Pericardial rub - REQUIRES HEADPHONES</a></td></tr><tr><td><span ><small>Thinklabs - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_314\" data-mediaid=\"314\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_314\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_314\" data-mediaid=\"314\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_314\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lJrXD9bJlI8\" data-description=\"Pericarditis\" data-upvotes=\"3\" data-downvotes=\"3\" data-media=\"278\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/lJrXD9bJlI8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/lJrXD9bJlI8\" data-description=\"Pericarditis\" data-upvotes=\"3\" data-downvotes=\"3\" data-media=\"278\">Pericarditis</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_475\" data-mediaid=\"475\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_475\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_475\" data-mediaid=\"475\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_475\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr></table>",
        "comment_count": 11,
        "concepts_for_notes": {
            "1281": {
                "concept_text": "Saddle-shaped ST elevation is often seen in the ECG of a patient with acute pericarditis\r\n",
                "concept_percentile": "47"
            },
            "9669": {
                "concept_text": "Global ST and PR segment changes: think pericarditis",
                "concept_percentile": "77"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "21696_B_118",
        "new_question_id": "45031",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "11348",
        "notes_id_link": "1_790",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Budesonide",
            "Infliximab",
            "Mercaptopurine",
            "Mesalazine",
            "Prednisolone",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 23-year-old woman presents to a gastrointestinal outpatient clinic following admission with the first presentation of Crohn's disease. She has now recovered and would like to start medication to prevent recurrent flares of Crohn's.<br /><br />What is the first-line medication to maintain remission in a patient with this condition?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "The first-line medication which is used to maintain remission in Crohn's is azathioprine or <b>mercaptopurine</b>. These medications are used once an acute flare has been controlled using steroids, with the aim of preventing further acute flares. <br /><br />Steroids such as <b>budesonide</b> and <b>prednisolone</b> are used in the treatment of Crohn's but usually to induce remission in these patients who are experiencing an acute flare. <br /><br /><b>Infliximab</b> is a biologic medication which is used to maintain the remission of Crohn's disease where other medications, such as mercaptopurine and azathioprine have failed. <br /><br /><b>Mesalazine</b> is an aminosalicylate which is usually used for the remission of ulcerative colitis. This medication is a second-line choice in Crohn's disease to induce remission, with steroids being the first line choice.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 23-year-old woman presents to a gastrointestinal outpatient clinic following admission with the first presentation of Crohn's disease. She has now recovered and would like to start medication to prevent recurrent flares of Crohn's.<br /><br />What is the first-line medication to maintain remission in a patient with this condition?",
        "correct_answer": "3",
        "question_notes": "The first-line medication which is used to maintain remission in Crohn's is azathioprine or <b>mercaptopurine</b>. These medications are used once an acute flare has been controlled using steroids, with the aim of preventing further acute flares. <br /><br />Steroids such as <b>budesonide</b> and <b>prednisolone</b> are used in the treatment of Crohn's but usually to induce remission in these patients who are experiencing an acute flare. <br /><br /><b>Infliximab</b> is a biologic medication which is used to maintain the remission of Crohn's disease where other medications, such as mercaptopurine and azathioprine have failed. <br /><br /><b>Mesalazine</b> is an aminosalicylate which is usually used for the remission of ulcerative colitis. This medication is a second-line choice in Crohn's disease to induce remission, with steroids being the first line choice.",
        "answer_order": "3",
        "answer": "3",
        "title": "Crohn's disease: management",
        "body": "Crohn's disease is a form of inflammatory bowel disease. It commonly affects the terminal ileum and colon but may be seen anywhere from the mouth to anus. NICE published guidelines on the management of Crohn's disease in 2012.<br /><br />General points<br /><ul><li>patients should be strongly advised to stop smoking</li><li>some studies suggest an increased risk of relapse secondary to NSAIDs and the combined oral contraceptive pill but the evidence is patchy</li></ul><br />Inducing remission<br /><ul><li><span class=\"concept\" data-cid=\"4699\">glucocorticoids (oral, topical or intravenous) are generally used to induce remission</span>. Budesonide is an alternative in a subgroup of patients</li><li>enteral feeding with an elemental diet may be used in addition to or instead of other measures to induce remission, particularly if there is concern regarding the side-effects of steroids (for example in young children)</li><li>5-ASA drugs (e.g. mesalazine) are used second-line to glucocorticoids but are not as effective</li><li>azathioprine or mercaptopurine* may be used as an add-on medication to induce remission but is not used as monotherapy. Methotrexate is an alternative to azathioprine</li><li>infliximab is useful in refractory disease and fistulating Crohn's. Patients typically continue on azathioprine or methotrexate</li><li>metronidazole is often used for isolated peri-anal disease</li></ul><br />Maintaining remission<br /><ul><li>as above, stopping smoking is a priority (remember: smoking makes Crohn's worse, but may help ulcerative colitis)</li><li><span class=\"concept\" data-cid=\"11348\">azathioprine or mercaptopurine</span> is used first-line to maintain remission </li></ul>   +<span class=\"concept\" data-cid=\"5503\">TPMT activity</span> should be assessed before starting<br /><ul><li>methotrexate is used second-line</li></ul><br />Surgery<br /><ul><li>around 80% of patients with Crohn's disease will eventually have surgery</li><li>stricturing terminal ileal disease &rarr; ileocaecal resection</li><li>segmental small bowel resections </li><li>stricturoplasty</li><li>perianal fistulae<ul><li>an inflammatory tract or connection between the anal canal and the perianal skin</li><li><span class=\"concept\" data-cid=\"11560\">MRI</span> is the investigation of choice for suspected perianal fistulae - can be used to determine if there (is an abscess and if the fistula is simple (low fistula) or complex (high fistula that passes through or above muscle layers)</li><li>patients with symptomatic perianal fistulae are usually given oral <span class=\"concept\" data-cid=\"11559\">metronidazole</span></li><li>anti-TNF agents such as infliximab may also be effective in closing and maintaining closure of perianal fistulas</li><li>a <span class=\"concept\" data-cid=\"11561\">draining seton</span> is used for complex fistulae</li><li>a seton is a piece of surgical thread that's left in the fistula for several weeks to keep it open. This is useful because persisting fistula tracks after premature skin closure predispose to abscess formation </li></ul></li><li>perianal abscess<ul><li>requires <span class=\"concept\" data-cid=\"11563\">incision and drainage</span> combined with antibiotic therapy</li><li>a draining seton may also be placed if a tract is identified</li></ul></li></ul><br /><br /><h5 class='notes-heading'>Complications of Crohn's disease</h5><br />As well as the well-documented complications described above, patients are also at risk of:<br /><ul><li>small bowel cancer (standard incidence ratio = 40)</li><li>colorectal cancer (standard incidence ratio = 2, i.e. less than the risk associated with ulcerative colitis)</li><li>osteoporosis</li></ul><br />*assess thiopurine methyltransferase (TPMT) activity before offering azathioprine or mercaptopurine",
        "notes_hash": "dceb04fc9cd8c79c8a662c778af3966d",
        "knowledge_graph_node_id_link": 1006,
        "concept": "Azathioprine or mercaptopurine is used first-line to maintain remission in patients with Crohn's",
        "concept_percentile": "88",
        "concept_colour": "rgb(61,255,0)",
        "number_attempts": "4867",
        "up_votes": "10",
        "down_votes": "9",
        "column_array": [
            0,
            "194",
            "258",
            "1661",
            "2229",
            "525",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_151\" data-linkid=\"151\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_151\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">25</span><button type=\"button\" style=\"\" id=\"link_dislike_151\" data-linkid=\"151\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_151\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng129/chapter/Recommendations\">2019 Crohn disease guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jYmpIjciPig\" data-description=\"Crohn's disease\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"58\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/jYmpIjciPig/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jYmpIjciPig\" data-description=\"Crohn's disease\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"58\">Crohn's disease</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_105\" data-mediaid=\"105\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_105\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_105\" data-mediaid=\"105\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_105\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 0,
        "concepts_for_notes": {
            "4699": {
                "concept_text": "Glucocorticoids (oral, topical or intravenous) are generally used to induce remission of Crohn's disease",
                "concept_percentile": "97"
            },
            "11348": {
                "concept_text": "Azathioprine or mercaptopurine is used first-line to maintain remission in patients with Crohn's",
                "concept_percentile": "88"
            },
            "11560": {
                "concept_text": "MRI is the investigation of choice for suspected perianal fistulae in patients with Crohn's ",
                "concept_percentile": "61"
            },
            "11561": {
                "concept_text": "A draining seton is used for complex perianal fistulae in patients with Crohn's disease",
                "concept_percentile": "49"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "13867_B_31",
        "new_question_id": "34596",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "11516",
        "notes_id_link": "1_1178",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Administer 1mg adrenaline",
            "Administer 300mg amiodarone",
            "Deliver a single synchronised DC shock followed by 2 minutes of 30:2 compressions",
            "Deliver three quick successive stacked unsynchronised DC shocks followed by 2 minutes of 30:2 compressions",
            "Start chest compressions at a rate of 30:2",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "An emergency buzzer goes off on the coronary care unit and you are the first doctor on the scene. A healthcare assistant whilst on an observation round found a 74-year-old man unresponsive. You tilt the head and chin lift and feel for a carotid pulse for 10 seconds whilst listening for breath, you feel neither a pulse nor hear breath sounds.<br /><br />Telemetry attached to the patient is showing sinus rhythm at a rate of 120bpm. The crash team is being called and the crash trolley is brought bedside. You are not aware of a DNACPR.<br /><br />What is the most appropriate initial action?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "Answer: <b>start chest compressions at a rate of 30:2</b>. This patient is in cardiac arrest with a 'non-shockable' rhythm (pulseless-electrical activity). Chest compression should immediately be started at a rate of 30:2 rescue breaths.<br /><br /><b>Administer 1mg adrenaline</b> is inappropriate as the initial action. Once chest compressions have started adrenaline may be administered as quickly as possible.<br /><br /><b>Administer 300mg amiodarone</b> is inappropriate. Amiodarone should be given to patients in ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT).<br /><br /><b>Deliver a single synchronised DC shock followed by 2 minutes of 30:2 compressions</b> is incorrect as the patient is in PEA a non-shockable rhythm. This would be appropriate if the rhythm were shockable (for example ventricular fibrillation or pulseless VT) and the patient was not on telemetry, in which case you would deliver three quick successive stacked shocks.<br /><br /><b>Deliver three quick successive stacked unsynchronised DC shocks followed by 2 minutes of 30:2 compressions</b> is incorrect as this patient is in PEA and this is a non-shockable rhythm. This would be appropriate if the patient were in a shockable rhythm whilst on telemetry.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "An emergency buzzer goes off on the coronary care unit and you are the first doctor on the scene. A healthcare assistant whilst on an observation round found a 74-year-old man unresponsive. You tilt the head and chin lift and feel for a carotid pulse for 10 seconds whilst listening for breath, you feel neither a pulse nor hear breath sounds.<br /><br />Telemetry attached to the patient is showing sinus rhythm at a rate of 120bpm. The crash team is being called and the crash trolley is brought bedside. You are not aware of a DNACPR.<br /><br />What is the most appropriate initial action?",
        "correct_answer": "5",
        "question_notes": "Answer: <b>start chest compressions at a rate of 30:2</b>. This patient is in cardiac arrest with a 'non-shockable' rhythm (pulseless-electrical activity). Chest compression should immediately be started at a rate of 30:2 rescue breaths.<br /><br /><b>Administer 1mg adrenaline</b> is inappropriate as the initial action. Once chest compressions have started adrenaline may be administered as quickly as possible.<br /><br /><b>Administer 300mg amiodarone</b> is inappropriate. Amiodarone should be given to patients in ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT).<br /><br /><b>Deliver a single synchronised DC shock followed by 2 minutes of 30:2 compressions</b> is incorrect as the patient is in PEA a non-shockable rhythm. This would be appropriate if the rhythm were shockable (for example ventricular fibrillation or pulseless VT) and the patient was not on telemetry, in which case you would deliver three quick successive stacked shocks.<br /><br /><b>Deliver three quick successive stacked unsynchronised DC shocks followed by 2 minutes of 30:2 compressions</b> is incorrect as this patient is in PEA and this is a non-shockable rhythm. This would be appropriate if the patient were in a shockable rhythm whilst on telemetry.",
        "answer_order": "5",
        "answer": "5",
        "title": "Adult advanced life support",
        "body": "The following is based on the 2021 Resus Council guidelines. Please see the link for more details, below is only a very brief summary of key points.<br /><br />It should be remembered that the algorithm divides patients into those with:<br /><ul><li>'shockable' rhythms:  ventricular fibrillation/pulseless ventricular tachycardia (VF/pulseless VT)</li><li>'non-shockable' rhythms: asystole/pulseless-electrical activity (asystole/PEA)</li></ul><br />Major points include:<br /><ul><li>chest compressions<ul><li>the ratio of chest compressions to ventilation is <span class=\"concept\" data-cid=\"11516\">30:2</span></li><li>chest compressions are now continued while a defibrillator is charged</li></ul></li><li>defibrillation<ul><li><span class=\"concept\" data-cid=\"9130\">a single shock for VF/pulseless VT</span> followed by 2 minutes of CPR</li></ul></li><li>drug delivery<ul><li>IV access should be attempted and is first-line</li><li>if IV access cannot be achieved then drugs should be given via the <span class=\"concept\" data-cid=\"11515\">intraosseous route (IO)</span></li><li>delivery of drugs via a <span class=\"concept\" data-cid=\"11515\">tracheal tube is no longer recommended</span></li></ul></li><li>adrenaline<ul><li><span class=\"concept\" data-cid=\"8608\">adrenaline 1 mg as soon as possible for non-shockable rhythms</span></li><li>during a VF/VT cardiac arrest, <span class=\"concept\" data-cid=\"9925\">adrenaline 1 mg</span> is given once chest compressions have restarted after the third shock </li><li><span class=\"concept\" data-cid=\"11517\">repeat adrenaline 1mg every 3-5 minutes</span> whilst ALS continues</li></ul></li><li>amiodarone<ul><li><span class=\"concept\" data-cid=\"11518\">amiodarone 300 mg should be given to patients who are in VF/pulseless VT after 3 shocks</span> have been administered.</li><li><span class=\"concept\" data-cid=\"11519\">a further dose of amiodarone 150 mg should be given to patients who are in VF/pulseless VT after 5 shocks</span> have been administered</li><li><span class=\"concept\" data-cid=\"11520\">lidocaine</span> used as an alternative if amiodarone is not available or a local decision has been made to use lidocaine instead</li></ul></li><li><span class=\"concept\" data-cid=\"11521\">thrombolytic drugs</span><ul><li>should be considered if a pulmonary embolus  is suspected</li><li>if given, CPR should be continued for an extended period of <span class=\"concept\" data-cid=\"11522\">60-90 minutes</span></li></ul></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd964b.png\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd964.png\" alt=\"\" /></a></div></div></div><br />Other points<br /><ul><li><span class=\"concept\" data-cid=\"198\">atropine</span> is no longer recommended for routine use in asystole or pulseless electrical activity (PEA)</li><li>following successful resuscitation oxygen should be titrated to achieve saturations of 94-98%. This is to address the potential harm caused by hyperoxaemia</li></ul><br />Reversible causes of cardiac arrest:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>The 'Hs'</th><th>The 'Ts'</th></tr></thead><tbody><tr><td><ul><li>Hypoxia</li><li>Hypovolaemia</li><li>Hyperkalaemia, hypokalaemia, hypoglycaemia, hypocalcaemia, acidaemia and other metabolic disorders</li><li>Hypothermia</td><td></li><li>Thrombosis (coronary or pulmonary)</li><li><span class=\"concept\" data-cid=\"5831\">Tension pneumothorax</span></li><li>Tamponade - cardiac</li><li>Toxins</td></tr></tbody></table></div></li></ul>",
        "notes_hash": "01cd06e39a409427e046421edca879c8",
        "knowledge_graph_node_id_link": 11290,
        "concept": "In ALS, the ratio of chest compressions to ventilation is 30:2",
        "concept_percentile": "28",
        "concept_colour": "rgb(255,142,0)",
        "number_attempts": "5658",
        "up_votes": "11",
        "down_votes": "12",
        "column_array": [
            0,
            "1093",
            "68",
            "370",
            "639",
            "3488",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Resuscitation Council</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1018\" data-linkid=\"1018\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1018\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">67</span><button type=\"button\" style=\"\" id=\"link_dislike_1018\" data-linkid=\"1018\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1018\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">35</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.resus.org.uk/library/2021-resuscitation-guidelines/adult-advanced-life-support-guidelines\">2021 Advanced Life Support guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>Resuscitation Council</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_906\" data-linkid=\"906\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_906\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">42</span><button type=\"button\" style=\"\" id=\"link_dislike_906\" data-linkid=\"906\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_906\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">22</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.resus.org.uk/library/2021-resuscitation-guidelines/adult-basic-life-support-guidelines\">2021 Basic Life Support guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jQYHQr3ebLo\" data-description=\"RC (UK) Cardiac Arrest Management Demo\" data-upvotes=\"51\" data-downvotes=\"5\" data-media=\"1181\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/jQYHQr3ebLo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/jQYHQr3ebLo\" data-description=\"RC (UK) Cardiac Arrest Management Demo\" data-upvotes=\"51\" data-downvotes=\"5\" data-media=\"1181\">RC (UK) Cardiac Arrest Management Demo</a></td></tr><tr><td><span ><small>Resuscitation Council (UK) - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2037\" data-mediaid=\"2037\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2037\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">51</span><button type=\"button\" style=\"\" id=\"media_dislike_2037\" data-mediaid=\"2037\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2037\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": {
            "8608": {
                "concept_text": "ALS - give adrenaline in non-shockable rhythm as soon as possible",
                "concept_percentile": "72"
            },
            "9130": {
                "concept_text": "VF/pulseless VT should be treated with 1 shock as soon as identified",
                "concept_percentile": "41"
            },
            "9925": {
                "concept_text": "The recommended dose of adrenaline to give during advanced ALS is 1mg",
                "concept_percentile": "42"
            },
            "11515": {
                "concept_text": "In ALS, if IV access cannot be achieved then drugs should be given via the intraosseous route (IO) - the tracheal route is no longer recommended",
                "concept_percentile": "30"
            },
            "11516": {
                "concept_text": "In ALS, the ratio of chest compressions to ventilation is 30:2",
                "concept_percentile": "28"
            },
            "11517": {
                "concept_text": "In ALS, once adrenaline has been initially given it should be repeated every 3-5 minutes whilst ALS continues",
                "concept_percentile": "53"
            },
            "11518": {
                "concept_text": "In ALS, amiodarone 300 mg should be given to patients who are in VF/pulseless VT after 3 shocks have been administered.",
                "concept_percentile": "44"
            },
            "11519": {
                "concept_text": "In ALS, a further dose of amiodarone 150 mg should be given to patients who are in VF/pulseless VT after 5 shocks have been administered",
                "concept_percentile": "48"
            },
            "11521": {
                "concept_text": "Thrombolytic drugs should be considered during CPR if a PE is suspected",
                "concept_percentile": "71"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1634_B_32",
        "new_question_id": "8307",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_387",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Sodium valproate",
            "Phenytoin",
            "Lamotrigine",
            "Primidone",
            "Phenobarbitone",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 25-year-old female comes to see her GP with a positive pregnancy test following a missed period. Given her last menstrual period it is estimated that she is 4-5 weeks pregnant. Although the news is unexpected, she is happy to continue with the pregnancy, however she is a known epileptic and is concerned about her medication.<br /><br />Which of the following medications are recommended for epileptics in pregnancy?",
            "",
            ""
        ],
        "answers": [
            "3",
            "0",
            "0"
        ],
        "notes": [
            "Anti-epileptics in pregnancy can be a tricky subject. Many are known to cause severe congenital defects (both structural and intellectual) and as such the first line of care is good contraceptive advice and planning with the patient in question. This is however, not always possible and there will always be cases where a patient becomes pregnant whilst on anti-epileptic medication prior to consulting with a doctor.<br /><br />The recent MBRRACE-UK and the NICE guidelines both state that most women with epilepsy and of child bearing age are currently prescribed lamotrigine and during pregnancy this may require a dose increase. Phenytoin, phenobarbitone and sodium valproate are all known to have an adverse effect on cognitive abilities and therefore are usually avoided unless absolutely necessary.<br /><br />Lamotrigine, carbamazepine and levetiracetam are known to have the smallest effects on the developing foetus, however all epileptics who are either pregnant or are planning to become pregnant should be referred to specialist care as soon as possible.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 25-year-old female comes to see her GP with a positive pregnancy test following a missed period. Given her last menstrual period it is estimated that she is 4-5 weeks pregnant. Although the news is unexpected, she is happy to continue with the pregnancy, however she is a known epileptic and is concerned about her medication.<br /><br />Which of the following medications are recommended for epileptics in pregnancy?",
        "correct_answer": "3",
        "question_notes": "Anti-epileptics in pregnancy can be a tricky subject. Many are known to cause severe congenital defects (both structural and intellectual) and as such the first line of care is good contraceptive advice and planning with the patient in question. This is however, not always possible and there will always be cases where a patient becomes pregnant whilst on anti-epileptic medication prior to consulting with a doctor.<br /><br />The recent MBRRACE-UK and the NICE guidelines both state that most women with epilepsy and of child bearing age are currently prescribed lamotrigine and during pregnancy this may require a dose increase. Phenytoin, phenobarbitone and sodium valproate are all known to have an adverse effect on cognitive abilities and therefore are usually avoided unless absolutely necessary.<br /><br />Lamotrigine, carbamazepine and levetiracetam are known to have the smallest effects on the developing foetus, however all epileptics who are either pregnant or are planning to become pregnant should be referred to specialist care as soon as possible.",
        "answer_order": "3",
        "answer": "3",
        "title": "Epilepsy: pregnancy and breast feeding",
        "body": "The risks of uncontrolled epilepsy during pregnancy generally outweigh the risks of medication to the fetus. All women thinking about becoming pregnant should be advised to take folic acid 5mg per day well before pregnancy to minimise the risk of neural tube defects. Around 1-2% of newborns born to non-epileptic mothers have congenital defects. This rises to 3-4% if the mother takes antiepileptic medication.<br /><br />Other points<br /><ul><li>aim for monotherapy</li><li>there is no indication to monitor antiepileptic drug levels</li><li>sodium valproate: associated with neural tube defects</li><li>carbamazepine: often considered the least teratogenic of the older antiepileptics</li><li>phenytoin: associated with cleft palate</li><li>lamotrigine: studies to date suggest the rate of congenital malformations may be low. The dose of lamotrigine may need to be increased in pregnancy</li></ul><br /><span class=\"concept\" data-cid=\"669\">Breast feeding is generally considered safe for mothers taking antiepileptics</span> with the possible exception of the barbiturates<br /><br />It is advised that pregnant women taking phenytoin are given vitamin K in the last month of pregnancy to prevent clotting disorders in the newborn<br /><br /><h5 class='notes-heading'>Sodium valproate</h5><br />The November 2013 issue of the Drug Safety Update also carried a warning about new evidence showing a significant risk of neurodevelopmental delay in children following maternal use of sodium valproate.<br /><br />The update concludes that sodium valproate should not be used during pregnancy and in women of childbearing age unless clearly necessary. Women of childbearing age should not start treatment without specialist neurological or psychiatric advice.",
        "notes_hash": "804fff819c3352ec261391c6f59e7267",
        "knowledge_graph_node_id_link": 11266,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4717",
        "up_votes": "39",
        "down_votes": "12",
        "column_array": [
            0,
            "501",
            "189",
            "3933",
            "45",
            "49",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>SIGN</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_129\" data-linkid=\"129\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_129\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"link_dislike_129\" data-linkid=\"129\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_129\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.sign.ac.uk/media/1079/sign143_2018.pdf\">2018 Diagnosis and management of epilepsy in adults</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_120\" data-linkid=\"120\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_120\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">10</span><button type=\"button\" style=\"\" id=\"link_dislike_120\" data-linkid=\"120\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_120\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng217\">2022 Epilepsy guidelines</a></td></tr></table><br><br><table style='width:100%'><tr><td>Royal College of Obstetricians and Gynaecologists</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1242\" data-linkid=\"1242\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1242\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"link_dislike_1242\" data-linkid=\"1242\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1242\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg68_epilepsy.pdf\">2016 Epilepsy in Pregnancy</a></td></tr></table>",
        "media": "",
        "comment_count": 3,
        "concepts_for_notes": {
            "669": {
                "concept_text": "Breast feeding is acceptable with nearly all anti-epileptic drugs",
                "concept_percentile": "94"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1588",
        "new_question_id": "5683",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "0",
        "notes_id_link": "1_1900",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Switch to the equivalent zopiclone dose then slowly withdraw over the next 2 weeks",
            "Switch to the equivalent diazepam dose then slowly withdraw over the next 2 weeks",
            "Switch to the equivalent zopiclone dose then slowly withdraw over the next 2 months",
            "Switch to the equivalent chlordiazepoxide dose then slowly withdraw over the next 2 months",
            "Switch to the equivalent diazepam dose then slowly withdraw over the next 2 months",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "You review a 55-year-old woman who has become dependant on temazepam, which was initially prescribed as a hypnotic. She is keen to end her addiction to temazepam and asks for help. Her current dose is 20mg on. What is the most appropriate strategy?",
            "",
            ""
        ],
        "answers": [
            "5",
            "",
            ""
        ],
        "notes": [
            "The most appropriate strategy for this patient is to <b>switch to the equivalent diazepam dose then slowly withdraw over the next 2 months</b>. This approach is recommended because diazepam has a longer half-life than temazepam, which allows for a smoother and more gradual withdrawal process. Additionally, UK guidelines support using diazepam as the preferred benzodiazepine for withdrawal due to its long half-life and availability in lower doses, which facilitates gradual tapering.<br /><br />The first option, <b>switch to the equivalent zopiclone dose then slowly withdraw over the next 2 weeks</b>, is not ideal because zopiclone is a non-benzodiazepine hypnotic (Z-drug) with similar effects on GABA receptors as benzodiazepines but with a different chemical structure. While it may be used as an alternative hypnotic agent in some cases, it is not suitable for benzodiazepine withdrawal due to its short half-life and lack of evidence supporting its use in this context.<br /><br />Similarly, <b>switch to the equivalent zopiclone dose then slowly withdraw over the next 2 months</b> would also not be appropriate for the same reasons mentioned above. Zopiclone's short half-life and lack of evidence supporting its use in benzodiazepine withdrawal make it an unsuitable choice for this patient.<br /><br />The option to <b>switch to the equivalent chlordiazepoxide dose then slowly withdraw over the next 2 months</b> is also not ideal. Although chlordiazepoxide has a longer half-life than temazepam and can be used for alcohol withdrawal management, it is not recommended for benzodiazepine withdrawal due to limited evidence supporting its efficacy compared to diazepam.<br /><br />In conclusion, the best course of action in this case would be to switch the patient from temazepam to an equivalent dose of diazepam and then gradually taper the dose over a period of 2 months. This approach is supported by UK guidelines and offers the patient the best chance of successfully withdrawing from benzodiazepine dependence.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "You review a 55-year-old woman who has become dependant on temazepam, which was initially prescribed as a hypnotic. She is keen to end her addiction to temazepam and asks for help. Her current dose is 20mg on. What is the most appropriate strategy?",
        "correct_answer": "5",
        "question_notes": "The most appropriate strategy for this patient is to <b>switch to the equivalent diazepam dose then slowly withdraw over the next 2 months</b>. This approach is recommended because diazepam has a longer half-life than temazepam, which allows for a smoother and more gradual withdrawal process. Additionally, UK guidelines support using diazepam as the preferred benzodiazepine for withdrawal due to its long half-life and availability in lower doses, which facilitates gradual tapering.<br /><br />The first option, <b>switch to the equivalent zopiclone dose then slowly withdraw over the next 2 weeks</b>, is not ideal because zopiclone is a non-benzodiazepine hypnotic (Z-drug) with similar effects on GABA receptors as benzodiazepines but with a different chemical structure. While it may be used as an alternative hypnotic agent in some cases, it is not suitable for benzodiazepine withdrawal due to its short half-life and lack of evidence supporting its use in this context.<br /><br />Similarly, <b>switch to the equivalent zopiclone dose then slowly withdraw over the next 2 months</b> would also not be appropriate for the same reasons mentioned above. Zopiclone's short half-life and lack of evidence supporting its use in benzodiazepine withdrawal make it an unsuitable choice for this patient.<br /><br />The option to <b>switch to the equivalent chlordiazepoxide dose then slowly withdraw over the next 2 months</b> is also not ideal. Although chlordiazepoxide has a longer half-life than temazepam and can be used for alcohol withdrawal management, it is not recommended for benzodiazepine withdrawal due to limited evidence supporting its efficacy compared to diazepam.<br /><br />In conclusion, the best course of action in this case would be to switch the patient from temazepam to an equivalent dose of diazepam and then gradually taper the dose over a period of 2 months. This approach is supported by UK guidelines and offers the patient the best chance of successfully withdrawing from benzodiazepine dependence.",
        "answer_order": "5",
        "answer": "5",
        "title": "Benzodiazepines",
        "body": "Benzodiazepines enhance the effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) by increasing the <b>frequency</b> of chloride channels. They therefore are used for a variety of purposes:<br /><ul><li>sedation</li><li>hypnotic</li><li>anxiolytic </li><li>anticonvulsant</li><li>muscle relaxant</li></ul><br />Patients commonly develop a tolerance and dependence to benzodiazepines and care should therefore be exercised on prescribing these drugs. The Committee on Safety of Medicines advises that benzodiazepines are only prescribed for a short period of time (2-4 weeks).<br /><br />The BNF gives advice on how to withdraw a benzodiazepine. The dose should be withdrawn in steps of about <span class=\"concept\" data-cid=\"12518\">1/8 (range 1/10 to 1/4) of the daily dose every fortnight</span>. A suggested protocol for patients experiencing difficulty is given:<br /><ul><li>switch patients to the equivalent dose of diazepam</li><li>reduce dose of diazepam every 2-3 weeks in steps of 2 or 2.5 mg</li><li>time needed for withdrawal can vary from 4 weeks to a year or more</li></ul><br />If patients withdraw too quickly from benzodiazepines they may experience benzodiazepine withdrawal syndrome, a condition very similar to alcohol withdrawal syndrome. This may occur up to 3 weeks after stopping a long-acting drug. Features include:<br /><ul><li>insomnia</li><li>irritability</li><li>anxiety</li><li>tremor</li><li>loss of appetite</li><li>tinnitus</li><li>perspiration</li><li>perceptual disturbances</li><li>seizures</li></ul><br /><div class='alert alert-warning'>GABA<sub>A</sub> drugs<br /><ul><li>benzodiazipines increase the <b>frequency</b> of chloride channels</li><li>barbiturates increase the <b>duration</b> of chloride channel opening</li></ul><br /><b>Freq</b>uently <b>Ben</b>d  - <b>Dur</b>ing <b>Barb</b>eque<br /><br />...or...<br /><br />Barbi<b>durat</b>es increase <b>durat</b>ion & <b>Fre</b>ndodiazepines increase <b>fre</b>quency<br /></div>",
        "notes_hash": "eb9d96b5aa49475798ff324ff4c1c402",
        "knowledge_graph_node_id_link": 10652,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5566",
        "up_votes": "32",
        "down_votes": "38",
        "column_array": [
            0,
            "629",
            "1146",
            "704",
            "832",
            "2255",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4ZHudeMho8g\" data-description=\"Benzodiazepines, bariburates and hypnotics (made easy)\" data-upvotes=\"9\" data-downvotes=\"3\" data-media=\"731\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/4ZHudeMho8g/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/4ZHudeMho8g\" data-description=\"Benzodiazepines, bariburates and hypnotics (made easy)\" data-upvotes=\"9\" data-downvotes=\"3\" data-media=\"731\">Benzodiazepines, bariburates and hypnotics (made easy)</a></td></tr><tr><td><span ><small>Speed Pharmacology - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1275\" data-mediaid=\"1275\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1275\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_1275\" data-mediaid=\"1275\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1275\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3</span></td></tr></table>",
        "comment_count": 8,
        "concepts_for_notes": {
            "12518": {
                "concept_text": "Stopping benzodiazepines: the dose should be withdrawn in steps of about 1/8 of the daily dose every fortnight",
                "concept_percentile": "92"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_115",
        "new_question_id": "5503",
        "question_type": "1",
        "category": "5",
        "concept_id_link": "0",
        "notes_id_link": "1_1873",
        "theme": "Respiratory pathogens",
        "instruction": "For each of the following scenarios please select the most likely causative respiratory pathogen:",
        "options": [
            "",
            "Adenovirus",
            "Parainfluenza virus",
            "<i>Mycobacterium tuberculosis</i>",
            "Pneumocystis jiroveci",
            "Respiratory syncytial virus",
            "<i>Mycoplasma pneumoniae</i>",
            "Rhinovirus",
            "<i>Legionella pneumophilia</i>",
            "<i><i>Streptococcus</i> pneumoniae</i>",
            "Influenza virus"
        ],
        "num_of_options": 10,
        "questions": [
            "A 14-month-old boy who has a barking cough which is worse at night.",
            "T 33-rxtk-hew ftg pah bl dghpg mh ux ABO ihlbmbox ikxlxgml pbma vhnza tgw wrlighxt. Tnlvnemtmbhg hy abl vaxlm bl ngkxftkdtuex unm ax bl ghmxw mh wxltmnktmx hg xqxkmbhg.",
            "T 30-rxtk-hew phftg ikxlxgml pbma t axtwtvax, frtezbt, yxoxk tgw t vhnza. Hg tnlvnemtmbhg axk vaxlm bl vextk unm lax atl t mxfixktmnkx hy 38.6&#186;V."
        ],
        "answers": [
            "2",
            "4",
            "10"
        ],
        "notes": [
            "",
            "",
            "These are typical flu symptoms. Influenza is much more common than Mycoplasma pneumonia."
        ],
        "exam_specific_explanation": "",
        "question": "A 14-month-old boy who has a barking cough which is worse at night.",
        "correct_answer": "2",
        "question_notes": "",
        "answer_order": "2",
        "answer": "2",
        "title": "Respiratory pathogens",
        "body": "The table below lists the more common respiratory pathogens:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Pathogen</b></th><th><b>Associated condition</b></th></tr></thead><tbody><tr><td>Respiratory syncytial virus</td><td>Bronchiolitis</td></tr><tr><td>Parainfluenza virus</td><td>Croup</td></tr><tr><td>Rhinovirus</td><td><span class=\"concept\" data-cid=\"8738\">Common cold</span></td></tr><tr><td>Influenza virus</td><td>Flu</td></tr><tr><td><i>Streptococcus pneumoniae</i></td><td>The most common cause of <span class=\"concept\" data-cid=\"8739\">community-acquired pneumonia</span></td></tr><tr><td><i>Haemophilus influenzae</i></td><td>Community-acquired pneumonia<br />Most common cause of <span class=\"concept\" data-cid=\"8741\">bronchiectasis exacerbations</span><br /><span class=\"concept\" data-cid=\"8742\">Acute epiglottitis</span></td></tr><tr><td><i>Staphylococcus aureus</i></td><td>Pneumonia, particularly <span class=\"concept\" data-cid=\"8740\">following influenza</span></td></tr><tr><td><i>Mycoplasma pneumoniae</i></td><td>Atypical pneumonia<br /><br />Flu-like symptoms classically precede a dry cough. Complications include haemolytic anaemia and erythema multiforme</td></tr><tr><td><i>Legionella pneumophilia</i></td><td>Atypical pneumonia<br /><br />Classically spread by air-conditioning systems, causes dry cough. Lymphopenia, deranged liver function tests and hyponatraemia may be seen</td></tr><tr><td>Pneumocystis jiroveci</td><td>Common cause of pneumonia in HIV patients. Typically patients have few chest signs and develop exertional dyspnoea</td></tr><tr><td><i>Mycobacterium tuberculosis</i></td><td>Causes tuberculosis. A wide range of presentations from asymptomatic to disseminated disease are possible. Cough, night sweats and weight loss may be seen</td></tr></tbody></table></div>",
        "notes_hash": "49b542ee852fea31ca550b67167448bd",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4140",
        "up_votes": "39",
        "down_votes": "35",
        "column_array": [
            0,
            "2854",
            "3876",
            "1975",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "",
        "comment_count": 5,
        "concepts_for_notes": {
            "8738": {
                "concept_text": "Common cold - rhinovirus",
                "concept_percentile": "43"
            },
            "8739": {
                "concept_text": "Community-acquired pneumonia - <i>Streptococcus pneumoniae</i>",
                "concept_percentile": "53"
            },
            "8740": {
                "concept_text": "Pneumonia following influenza - <i>Staphylococcus aureus</i>",
                "concept_percentile": "24"
            },
            "8741": {
                "concept_text": "Exacerbation of bronchiectasis - <i>Haemophilus influenzae</i>",
                "concept_percentile": "70"
            },
            "8742": {
                "concept_text": "Acute epiglottitis - <i>Haemophilus influenzae</i>",
                "concept_percentile": "44"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_586",
        "new_question_id": "9236",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "0",
        "notes_id_link": "1_561",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Myasthenia gravis precipitated by bendroflumethiazide",
            "Oesophageal web",
            "Achalasia secondary to amlodipine",
            "Oesophageal candidiasis",
            "Oesophageal cancer",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 64-year-old female with a history of COPD and hypertension presents with pain on swallowing. Current medication includes a salbutamol and beclomethasone inhaler, bendroflumethiazide and amlodipine. What is the most likely cause of the presentation?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer is oesophageal candidiasis. This patient is using an inhaled corticosteroid (beclomethasone) for COPD, which is a significant risk factor for developing oropharyngeal and oesophageal candidiasis. The local immunosuppressive effects of inhaled corticosteroids create an environment conducive to fungal growth, particularly <i>Candida albicans</i>. Odynophagia (pain on swallowing) is a classic symptom of oesophageal candidiasis, and the combination of risk factor and symptom makes this the most likely diagnosis.<br /><br /><b>Myasthenia gravis precipitated by bendroflumethiazide</b> is incorrect because while bendroflumethiazide can theoretically exacerbate myasthenia gravis, this would typically present with generalised muscle weakness, ptosis, and diplopia rather than isolated odynophagia. Additionally, new-onset myasthenia gravis at age 64 would be relatively unusual.<br /><br /><b>Oesophageal web</b> is incorrect because while this can cause dysphagia (difficulty swallowing), it typically causes non-painful dysphagia, particularly to solid foods, rather than odynophagia. Oesophageal webs are also more commonly associated with iron deficiency anaemia (Plummer-Vinson syndrome) and typically affect middle-aged women.<br /><br /><b>Achalasia secondary to amlodipine</b> is incorrect because amlodipine does not cause achalasia. While calcium channel blockers can actually be used to treat achalasia, they do not cause it. Furthermore, achalasia typically presents with dysphagia to both solids and liquids, and regurgitation, rather than odynophagia.<br /><br /><b>Oesophageal cancer</b> is incorrect because while this should always be considered in older patients with swallowing difficulties, it typically presents with progressive dysphagia (initially to solids, then liquids) rather than acute onset odynophagia. While pain can occur in advanced disease, it would usually be accompanied by other symptoms such as weight loss and anorexia.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 64-year-old female with a history of COPD and hypertension presents with pain on swallowing. Current medication includes a salbutamol and beclomethasone inhaler, bendroflumethiazide and amlodipine. What is the most likely cause of the presentation?",
        "correct_answer": "4",
        "question_notes": "The correct answer is oesophageal candidiasis. This patient is using an inhaled corticosteroid (beclomethasone) for COPD, which is a significant risk factor for developing oropharyngeal and oesophageal candidiasis. The local immunosuppressive effects of inhaled corticosteroids create an environment conducive to fungal growth, particularly <i>Candida albicans</i>. Odynophagia (pain on swallowing) is a classic symptom of oesophageal candidiasis, and the combination of risk factor and symptom makes this the most likely diagnosis.<br /><br /><b>Myasthenia gravis precipitated by bendroflumethiazide</b> is incorrect because while bendroflumethiazide can theoretically exacerbate myasthenia gravis, this would typically present with generalised muscle weakness, ptosis, and diplopia rather than isolated odynophagia. Additionally, new-onset myasthenia gravis at age 64 would be relatively unusual.<br /><br /><b>Oesophageal web</b> is incorrect because while this can cause dysphagia (difficulty swallowing), it typically causes non-painful dysphagia, particularly to solid foods, rather than odynophagia. Oesophageal webs are also more commonly associated with iron deficiency anaemia (Plummer-Vinson syndrome) and typically affect middle-aged women.<br /><br /><b>Achalasia secondary to amlodipine</b> is incorrect because amlodipine does not cause achalasia. While calcium channel blockers can actually be used to treat achalasia, they do not cause it. Furthermore, achalasia typically presents with dysphagia to both solids and liquids, and regurgitation, rather than odynophagia.<br /><br /><b>Oesophageal cancer</b> is incorrect because while this should always be considered in older patients with swallowing difficulties, it typically presents with progressive dysphagia (initially to solids, then liquids) rather than acute onset odynophagia. While pain can occur in advanced disease, it would usually be accompanied by other symptoms such as weight loss and anorexia.",
        "answer_order": "4",
        "answer": "4",
        "title": "Dysphagia",
        "body": "The table below gives characteristic exam question features for conditions causing dysphagia. Remember that <span class=\"concept\" data-cid=\"1553\">new-onset dysphagia is a red flag symptom</span> that requires urgent endoscopy, regardless of age or other symptoms.<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Causes</th><th>Notes</th></tr></thead><tbody><tr><td><b><span class=\"concept\" data-cid=\"8031\">Oesophageal cancer</span></b></td><td>Dysphagia may be associated with weight loss, anorexia or vomiting during eating<br />Past history may include Barrett's oesophagus, GORD, excessive smoking or alcohol use</td></tr><tr><td><b><span class=\"concept\" data-cid=\"8033\">Oesophagitis</span></b></td><td>There may be a history of heartburn<br />Odynophagia but no weight loss and systemically well</td></tr><tr><td><b><span class=\"concept\" data-cid=\"8032\">Oesophageal candidiasis</span></b></td><td>There may be a history of HIV or other risk factors such as steroid inhaler use</td></tr><tr><td><b>Achalasia</b></td><td>Dysphagia of <span class=\"concept\" data-cid=\"8238\">both liquids and solids from the start</span><br />Heartburn<br />Regurgitation of food - may lead to cough, aspiration pneumonia etc</td></tr><tr><td><b><span class=\"concept\" data-cid=\"8034\">Pharyngeal pouch</span></b></td><td>More common in older men<br />Represents a posteromedial herniation between thyropharyngeus and cricopharyngeus muscles<br />Usually not seen but if large then a midline lump in the neck that gurgles on palpation<br />Typical symptoms are dysphagia, regurgitation, aspiration and chronic cough. Halitosis may occasionally be seen</td></tr><tr><td><b><span class=\"concept\" data-cid=\"8035\">Systemic sclerosis</span></b></td><td>Other features of CREST syndrome may be present, namely Calcinosis, Raynaud's phenomenon, oEsophageal dysmotility, Sclerodactyly, Telangiectasia<br /><br />As well as oesophageal dysmotility the lower oesophageal sphincter (LES) pressure is decreased. This contrasts to achalasia where the LES pressure is increased</td></tr><tr><td><b><span class=\"concept\" data-cid=\"8030\">Myasthenia gravis</span></b></td><td>Other symptoms may include extraocular muscle weakness or ptosis<br />Dysphagia with liquids as well as solids</td></tr><tr><td><b><span class=\"concept\" data-cid=\"8029\">Globus hystericus</span></b></td><td>There may be a history of anxiety<br />Symptoms are often intermittent and relieved by swallowing<br />Usually painless - the presence of pain should warrant further investigation for organic causes</td></tr></tbody></table></div><br /><br /><h5 class='notes-heading'>Causes of dysphagia - by classification</h5><br />As with many conditions, it's often useful to think about causes of a symptom in a structured way:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th>Classification</th><th>Examples</th></tr></thead><tbody><tr><td><b>Extrinsic</b></td><td><ul><li>Mediastinal masses</li><li>Cervical spondylosis</td></tr><tr><td></li></ul><b>Oesophageal wall</b></td><td><ul><li>Achalasia</li><li>Diffuse oesophageal spasm</li><li>Hypertensive lower oesophageal sphincter</td></tr><tr><td></li></ul><b>Intrinsic</b></td><td><ul><li>Tumours</li><li>Strictures</li><li>Oesophageal web</li><li>Schatzki rings</td></tr><tr><td></li></ul><b>Neurological</b></td><td><ul><li>CVA</li><li>Parkinson's disease</li><li>Multiple Sclerosis</li><li>Brainstem pathology</li><li>Myasthenia Gravis</td></tr></tbody></table></div></li></ul><br /><h5 class='notes-heading'>Investigation</h5><br />All patients require an upper GI endoscopy unless there are compelling reasons for this not to be performed. Motility disorders may be best appreciated by undertaking fluoroscopic swallowing studies. <br /><br />A full blood count should be performed.<br /><br />Ambulatory oesophageal pH and manometry studies will be required to evaluate conditions such as achalasia and patients with GORD being considered for fundoplication surgery.",
        "notes_hash": "6c92ecf4a144ed596025443d43075c0b",
        "knowledge_graph_node_id_link": 10116,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "7554",
        "up_votes": "49",
        "down_votes": "13",
        "column_array": [
            0,
            "92",
            "154",
            "206",
            "6877",
            "225",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rkGJnEr1MF0\" data-description=\"Dysphagia (difficulty swallowing) - causes, pathophysiology, classification, investigation\" data-upvotes=\"8\" data-downvotes=\"0\" data-media=\"1108\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/rkGJnEr1MF0/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/rkGJnEr1MF0\" data-description=\"Dysphagia (difficulty swallowing) - causes, pathophysiology, classification, investigation\" data-upvotes=\"8\" data-downvotes=\"0\" data-media=\"1108\">Dysphagia (difficulty swallowing) - causes, pathophysiology, classification, investigation</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1918\" data-mediaid=\"1918\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1918\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"media_dislike_1918\" data-mediaid=\"1918\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1918\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 4,
        "concepts_for_notes": {
            "1553": {
                "concept_text": "New-onset dysphagia is a red flag symptom that requires urgent endoscopy, regardless of age or other symptoms",
                "concept_percentile": "73"
            },
            "8029": {
                "concept_text": "A patient with a history of anxiety complains of having a 'lump' in her throat - globus hystericus",
                "concept_percentile": "27"
            },
            "8030": {
                "concept_text": "A woman complains of lethargy, diplopia and dysphagia. She is noted to have a ptosis on examination - myasthenia gravis",
                "concept_percentile": "39"
            },
            "8031": {
                "concept_text": "A patient with a known history of Barrett's oesophagus presents with dysphagia and weight loss - oesophageal cancer",
                "concept_percentile": "94"
            },
            "8032": {
                "concept_text": "A patient who is known to have HIV presents with odynophagia - oesophageal candidiasis",
                "concept_percentile": "30"
            },
            "8033": {
                "concept_text": "A patient with a history of heartburn presents with odynophagia. There no weight loss, vomiting or anorexia - oesophagitis",
                "concept_percentile": "38"
            },
            "8034": {
                "concept_text": "An elderly man complains of dysphagia, halitosis, regurgitation and cough - pharyngeal pouch",
                "concept_percentile": "38"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_12",
        "new_question_id": "3603",
        "question_type": "1",
        "category": "8",
        "concept_id_link": "0",
        "notes_id_link": "1_1613",
        "theme": "Drug monitoring",
        "instruction": "For each of the following drugs select the most appropriate monitoring tests once treatment has commenced",
        "options": [
            "",
            "U&E, LFT",
            "TFT, LFT",
            "TFT, U&E",
            "LFT",
            "FBC, U&E",
            "FBC, LFT",
            "LFT, creatine kinase",
            "Calcium",
            "ECG",
            "No routine monitoring required"
        ],
        "num_of_options": 10,
        "questions": [
            "Gliclazide",
            "Zyzsghnoqhmd",
            "Rhluzrszshm (ehqrs 12 lnmsgr ne sqdzsldms)"
        ],
        "answers": [
            "10",
            "6",
            "4"
        ],
        "notes": [
            "",
            "",
            "Creatine kinase levels do not need to be routinely monitored unless there is a suspicion of myopathy"
        ],
        "exam_specific_explanation": "",
        "question": "Gliclazide",
        "correct_answer": "10",
        "question_notes": "",
        "answer_order": "10",
        "answer": "10",
        "title": "Drug monitoring",
        "body": "The tables below show the monitoring requirements of common drugs. It should be noted these are basic guidelines and do not relate to monitoring effectiveness of treatment (e.g. Checking lipids for patients taking a statin)<br /><br /><h5 class='notes-heading'>Cardiovascular drugs</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Drug</b></th><th><b>Main monitoring parameters</b></th><th><b>Details of monitoring</b></th></tr></thead><tbody><tr><td>Statins</td><td>LFT</td><td>LFTs at baseline, 3 months and 12 months</td></tr><tr><td>ACE inhibitors</td><td>U&E</td><td>U&E prior to treatment<br />U&E after increasing dose<br />U&E at least annually</td></tr><tr><td>Amiodarone</td><td>TFT, LFT</td><td>TFT, LFT, U&E, CXR prior to treatment<br />TFT, LFT every 6 months</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Rheumatology drugs</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th><b>Drug</b></th><th><b>Main monitoring parameters</b></th><th><b>Details of monitoring</b></th></tr></thead><tbody><tr><td>Methotrexate</td><td>FBC, LFT, U&E</td><td>The Committee on Safety of Medicines recommend 'FBC and renal and LFTs before starting treatment and repeated weekly until therapy stabilised, thereafter patients should be monitored every 2-3 months'</td></tr><tr><td>Azathioprine</td><td>FBC, LFT</td><td>FBC, LFT before treatment<br />FBC weekly for the first 4 weeks<br />FBC, LFT every 3 months</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Neuropsychiatric drugs</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid3\" ><thead><tr><th><b>Drug</b></th><th><b>Main monitoring parameters</b></th><th><b>Details of monitoring</b></th></tr></thead><tbody><tr><td>Lithium</td><td>Lithium level, TFT, U&E</td><td>TFT, U&E prior to treatment<br />Lithium levels weekly until stabilised then every 3 months<br />TFT, U&E every 6 months</td></tr><tr><td>Sodium valproate</td><td>LFT</td><td>LFT, FBC before treatment<br />LFT 'periodically' during first 6 months</td></tr></tbody></table></div><br /><h5 class='notes-heading'>Endocrine drugs</h5><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid4\" ><thead><tr><th><b>Drug</b></th><th><b>Main monitoring parameters</b></th><th><b>Details of monitoring</b></th></tr></thead><tbody><tr><td>Glitazones</td><td>LFT</td><td>LFT before treatment<br />LFT 'regularly' during treatment</td></tr></tbody></table></div>",
        "notes_hash": "b1acdbf186336d20f9733d3d20e300ef",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "4173",
        "up_votes": "32",
        "down_votes": "70",
        "column_array": [
            0,
            "1973",
            "1925",
            "2217",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>British Society for Rheumatology</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1424\" data-linkid=\"1424\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1424\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"link_dislike_1424\" data-linkid=\"1424\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1424\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">6</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://academic.oup.com/rheumatology/article/56/6/865/3053478\">2017 Guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs</a></td></tr></table>",
        "media": "",
        "comment_count": 6,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "999_B_1520",
        "new_question_id": "59768",
        "question_type": "0",
        "category": "11",
        "concept_id_link": "11018",
        "notes_id_link": "1_1568",
        "theme": "Next step after failed pelvic floor training for stress incontinence",
        "instruction": "",
        "options": [
            "",
            "Start duloxetine",
            "Prescribe oxybutynin",
            "Refer for botulinum toxin injection",
            "Initiate bladder retraining",
            "Insert intramural bulking agent",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 54-year-old woman presents to her GP with a 9-month history of involuntary urine leakage, mainly when she coughs or lifts heavy objects. She has completed a 3-month course of pelvic floor muscle training without improvement and does not wish to consider surgery. She is otherwise healthy and takes no regular medication. Which is the most appropriate next step in management?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "<b>Start duloxetine</b>: Duloxetine is recommended by NICE as an option for women with stress urinary incontinence who have not responded to pelvic floor muscle exercises and do not wish to undergo surgical intervention. It works by increasing noradrenaline and serotonin at the pudendal nerve, enhancing urethral sphincter contraction. This makes it suitable for this patient who has persistent symptoms despite conservative therapy and declines surgery.<br /><br /><b>Prescribe oxybutynin</b>: Oxybutynin is an antimuscarinic agent used primarily for urge incontinence due to detrusor overactivity (overactive bladder), not stress incontinence. There is no evidence supporting its use in isolated stress incontinence, so it would be inappropriate here.<br /><br /><b>Refer for botulinum toxin injection</b>: Botulinum toxin A injections are indicated for overactive bladder symptoms refractory to antimuscarinics, particularly when urodynamic studies confirm detrusor overactivity. They are not appropriate for pure stress incontinence as seen in this case.<br /><br /><b>Initiate bladder retraining</b>: Bladder retraining is first-line management for urge urinary incontinence but has limited benefit in pure stress incontinence, where the problem relates to urethral sphincter weakness rather than abnormal bladder contractions.<br /><br /><b>Insert intramural bulking agent</b>: Bulking agents can be considered as a minimally invasive surgical option for stress urinary incontinence but still constitute a procedural intervention. The scenario specifies that the patient does not wish to consider surgery or procedures, so this would not be suitable.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 54-year-old woman presents to her GP with a 9-month history of involuntary urine leakage, mainly when she coughs or lifts heavy objects. She has completed a 3-month course of pelvic floor muscle training without improvement and does not wish to consider surgery. She is otherwise healthy and takes no regular medication. Which is the most appropriate next step in management?",
        "correct_answer": "1",
        "question_notes": "<b>Start duloxetine</b>: Duloxetine is recommended by NICE as an option for women with stress urinary incontinence who have not responded to pelvic floor muscle exercises and do not wish to undergo surgical intervention. It works by increasing noradrenaline and serotonin at the pudendal nerve, enhancing urethral sphincter contraction. This makes it suitable for this patient who has persistent symptoms despite conservative therapy and declines surgery.<br /><br /><b>Prescribe oxybutynin</b>: Oxybutynin is an antimuscarinic agent used primarily for urge incontinence due to detrusor overactivity (overactive bladder), not stress incontinence. There is no evidence supporting its use in isolated stress incontinence, so it would be inappropriate here.<br /><br /><b>Refer for botulinum toxin injection</b>: Botulinum toxin A injections are indicated for overactive bladder symptoms refractory to antimuscarinics, particularly when urodynamic studies confirm detrusor overactivity. They are not appropriate for pure stress incontinence as seen in this case.<br /><br /><b>Initiate bladder retraining</b>: Bladder retraining is first-line management for urge urinary incontinence but has limited benefit in pure stress incontinence, where the problem relates to urethral sphincter weakness rather than abnormal bladder contractions.<br /><br /><b>Insert intramural bulking agent</b>: Bulking agents can be considered as a minimally invasive surgical option for stress urinary incontinence but still constitute a procedural intervention. The scenario specifies that the patient does not wish to consider surgery or procedures, so this would not be suitable.",
        "answer_order": "1",
        "answer": "1",
        "title": "Urinary incontinence",
        "body": "Urinary incontinence (UI) is a common problem, affecting around 4-5% of the population. It is more common in elderly females. <br /><br />Risk factors<br /><ul><li>advancing age</li><li>previous pregnancy and childbirth</li><li>high body mass index</li><li>hysterectomy</li><li>family history</li></ul><br />Classification<br /><ul><li><span class=\"concept\" data-cid=\"11615\">overactive bladder (OAB)/urge incontinence</span><ul><li>due to detrusor overactivity</li><li>the urge to urinate is quickly followed by uncontrollable leakage ranging from a few drops to complete bladder emptying</li></ul></li><li>stress incontinence: leaking small amounts when <span class=\"concept\" data-cid=\"4783\">coughing or laughing</span></li><li>mixed incontinence: both urge and stress</li><li>overflow incontinence: due to <span class=\"concept\" data-cid=\"4782\">bladder outlet obstruction</span>, e.g. due to prostate enlargement</li><li><span class=\"concept\" data-cid=\"11553\">functional incontinence</span><ul><li>comorbid physical conditions impair the patient's ability to get to a bathroom in time</li><li>causes include dementia, sedating medication and injury/illness resulting in decreased ambulation</li></ul></li></ul><br />Initial investigation<br /><ul><li>bladder diaries should be completed for a minimum of 3 days</li><li>vaginal examination to exclude pelvic organ prolapse and ability to initiate voluntary contraction of pelvic floor muscles ('Kegel' exercises)</li><li><span class=\"concept\" data-cid=\"2860\">urine dipstick and culture</span></li><li>urodynamic studies<ul><li><span class=\"concept\" data-cid=\"12421\">not routinely required before starting initial conservative treatment for urinary incontinence</span></li><li>may be considered if the diagnosis is uncertain,  mixed incontinence is suspected or surgical intervention is planned</li></ul></li></ul><br /><h6 class='notes-subheading'>Management depends on whether urge or stress UI is the predominant picture</h6> <br /><br />If urge incontinence is predominant:<br /><ul><li><span class=\"concept\" data-cid=\"342\">bladder retraining</span> (lasts for a minimum of 6 weeks, the idea is to gradually increase the intervals between voiding) </li><li><span class=\"concept\" data-cid=\"4664\">bladder stabilising drugs: antimuscarinics are first-line</span><ul><li>NICE recommend oxybutynin (immediate release), tolterodine (immediate release) or darifenacin (once daily preparation)</li><li><span class=\"concept\" data-cid=\"8320\"> avoid immediate-release oxybutynin in frail older women</span></li><li>solifenacin is an alternative antimuscarinic agent</li></ul></li><li>mirabegron (a <span class=\"concept\" data-cid=\"2295\">beta-3 agonist</span>) may be useful if there is concern about anticholinergic side-effects in <span class=\"concept\" data-cid=\"7869\">frail elderly patients</span></li><li>if <span class=\"concept\" data-cid=\"12317\">troublesome nocturia is a feature, desmopressin</span> may be considered</li><li>for women with overactive bladder that has not responded to non-surgical management:<ul><li>if urodynamic investigations determine that detrusor overactivity is causing her overactive bladder symptoms then consider <span class=\"concept\" data-cid=\"12326\">botulinum toxin type A bladder wall injection</span></li></ul></li></ul><br />If stress incontinence is predominant:<br /><ul><li>lifestyle measures, e.g. weight reduction, reducing caffeine intake</li><li><span class=\"concept\" data-cid=\"342\">pelvic floor muscle training</span><ul><li>NICE recommend at least 8 contractions performed 3 times per day for a minimum of 3 months</li></ul></li><li>surgical procedures include:<ul><li>mid-urethral tape procedures (still recommended by NICE but only after discussing risks and benefits)</li><li>intramural bulking agent injections</li><li>colposuspension</li></ul></li><li><span class=\"concept\" data-cid=\"11018\">duloxetine</span> may be offered to women if they decline surgical procedures<ul><li>a combined noradrenaline and serotonin reuptake inhibitor</li><li>mechanism of action: increased synaptic concentration of noradrenaline and serotonin within the pudendal nerve &rarr; increased stimulation of urethral striated muscles within the sphincter &rarr; enhanced contraction</li></ul></li></ul>",
        "notes_hash": "6003d1ac7f9e8dcae13affdb7cd360c6",
        "knowledge_graph_node_id_link": 10100,
        "concept": "Duloxetine may be used in patients with stress incontinence who don't respond to pelvic floor muscle exercises and decline surgical intervention",
        "concept_percentile": "83",
        "concept_colour": "rgb(86,255,0)",
        "number_attempts": "2949",
        "up_votes": "0",
        "down_votes": "1",
        "column_array": [
            0,
            "2165",
            "511",
            "125",
            "80",
            "68",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_272\" data-linkid=\"272\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_272\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">25</span><button type=\"button\" style=\"\" id=\"link_dislike_272\" data-linkid=\"272\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_272\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">37</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng123/chapter/Recommendations\">2019 urinary incontinence guidelines</a></td></tr></table>",
        "media": "",
        "comment_count": 0,
        "concepts_for_notes": {
            "342": {
                "concept_text": "Urinary incontinence - first-line treatment:\r\n   - urge incontinence: bladder retraining\r\n   - stress incontinence: pelvic floor muscle training",
                "concept_percentile": "64"
            },
            "2860": {
                "concept_text": "Urine dipstick test and culture should be done as part of the basic investigations for urinary incontinence",
                "concept_percentile": "71"
            },
            "4664": {
                "concept_text": "Patients with urge incontinence who have failed bladder retraining can trial bladder stabilising drugs (antimuscarinics) such as oxybutynin, tolterodine or darifenacin",
                "concept_percentile": "85"
            },
            "4782": {
                "concept_text": "Bladder still palpable after urination, think retention with urinary overflow ",
                "concept_percentile": "85"
            },
            "4783": {
                "concept_text": "Urinary incontinence when coughing is most likely to be due to stress incontinence",
                "concept_percentile": "29"
            },
            "11018": {
                "concept_text": "Duloxetine may be used in patients with stress incontinence who don't respond to pelvic floor muscle exercises and decline surgical intervention",
                "concept_percentile": "83"
            },
            "12326": {
                "concept_text": "Botulinum toxin type A bladder wall injections may be considered for refactory overactive bladder symptoms",
                "concept_percentile": "91"
            }
        },
        "optimisation_reason": ""
    }
]